We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$89.6B
AUM Growth
-$307M
(-0.34%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
13.13%
Holding
1,015
New
93
Increased
423
Reduced
329
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$536M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
+$409M |
| 3 |
PepsiCo
PEP
|
+$325M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 5 |
PG&E
PCG
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras Class A
PBR.A
|
+$417M |
| 2 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
+$383M |
| 3 |
AGN
Allergan Inc
AGN
|
+$340M |
| 4 |
AbbVie
ABBV
|
+$257M |
| 5 |
Exelon
EXC
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.02% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 11.87% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Host Hotels & Resorts
HST
$17B
| $22.6M | 0.03% |
1,119,747
-1,218,840
| -52% | -$27.2M |
|
552
Acacia Research
ACTG
$446M
| $22.5M | 0.03% |
2,100,000
| – | – |
|
553
Manhattan Associates
MANH
$9.62B
| $22.4M | 0.03% |
441,690
+186,670
| +73% | +$9M |
|
|
FMER
554
DELISTED
FIRSTMERIT CORP
FMER
| $22.3M | 0.02% |
1,169,726
+22,710
| +2% | +$411K |
|
|
PGRE
555
DELISTED
Paramount Group
PGRE
| $22.3M | 0.02% |
1,154,050
+38,760
| +3% | +$737K |
|
|
DFT
556
DELISTED
DuPont Fabros Technology Inc.
DFT
| $22.2M | 0.02% |
679,718
+18,191
| +3% | +$614K |
|
|
ENV
557
DELISTED
ENVESTNET, INC.
ENV
| $22.1M | 0.02% |
394,090
-94,000
| -19% | -$5.02M |
|
|
LPNT
558
DELISTED
LifePoint Health, Inc.
LPNT
| $22.1M | 0.02% |
300,397
-185,990
| -38% | -$13.2M |
|
559
Ambarella
AMBA
$2.85B
| $22M | 0.02% |
291,050
+86,290
| +42% | +$5.24M |
|
560
Eldorado Gold
EGO
$8.46B
| $22M | 0.02% |
960,000
+130,000
| +16% | +$3.56M |
|
|
CMD
561
DELISTED
Cantel Medical Corporation
CMD
| $22M | 0.02% |
463,523
+31,010
| +7% | +$1.37M |
|
562
T. Rowe Price
TROW
$25.3B
| $22M | 0.02% |
271,409
+107,439
| +66% | +$8.85M |
|
563
Essent Group
ESNT
$6.12B
| $22M | 0.02% |
918,870
-44,390
| -5% | -$1.07M |
|
564
Associated Banc-Corp
ASB
$5.81B
| $21.7M | 0.02% |
1,169,290
| – | – |
|
565
Acco Brands
ACCO
$381M
| $21.7M | 0.02% |
2,614,090
+66,328
| +3% | +$526K |
|
566
Bank OZK
OZK
$5.53B
| $21.7M | 0.02% |
587,710
-483,930
| -45% | -$17.2M |
|
567
Allegion
ALLE
$13.3B
| $21.7M | 0.02% |
354,432
-406,500
| -53% | -$23.2M |
|
568
Papa John's
PZZA
$1.02B
| $21.6M | 0.02% |
+349,290
| New | +$21.8M |
|
569
Edwards Lifesciences
EW
$48.2B
| $21.5M | 0.02% |
907,200
+46,020
| +5% | +$1.03M |
|
570
Cognex
CGNX
$10B
| $21.5M | 0.02% |
+867,220
| New | +$18.4M |
|
571
Integra LifeSciences
IART
$1.54B
| $21.5M | 0.02% |
851,463
+21,859
| +3% | +$517K |
|
|
EXCU
572
DELISTED
Exelon Corporation
EXCU
| $21.3M | 0.02% |
438,190
+363,160
| +484% | +$18.5M |
|
573
MACOM Technology Solutions
MTSI
$19.6B
| $21.3M | 0.02% |
570,870
+349,320
| +158% | +$11.7M |
|
574
Cencora
COR
$60.7B
| $21.1M | 0.02% |
185,430
-8,890
| -5% | -$894K |
|
575
Consolidated Edison
ED
$41.2B
| $20.8M | 0.02% |
+341,650
| New | +$22.2M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2015 Portfolio in Review
As of Q1 2015, OppenheimerFunds held 1,015 positions worth $89.6B, down 0.34% from $89.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
OppenheimerFunds's Q1 2015 filing shows 93 new, 423 increased, 329 reduced and 118 closed positions. Its largest new stake was UBS Group: 30,806,912 shares worth $578M. The largest sale was Petrobras Class A, an estimated $417M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q1 2015 buy was UBS Group: 30,806,912 shares worth $578M.
- OppenheimerFunds added most to Williams Partners L.P. in Q1 2015, an estimated $409M increase.
- OppenheimerFunds's biggest Q1 2015 reduction was AbbVie, cutting an estimated $257M.
- OppenheimerFunds fully exited Petrobras Class A in Q1 2015, selling an estimated $417M.
- OppenheimerFunds's ten largest holdings make up 13% of its $89.6B portfolio in Q1 2015.
- OppenheimerFunds opened 93 new positions and closed 118 in Q1 2015.
- OppenheimerFunds's portfolio value fell 0.34% quarter-over-quarter to $89.6B.
Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.